tibenzonium-iodide has been researched along with Pain* in 1 studies
1 other study(ies) available for tibenzonium-iodide and Pain
| Article | Year |
|---|---|
Development and optimization of tibezonium iodide and lignocaine hydrochloride containing novel mucoadhesive buccal tablets: a pharmacokinetic investigation among healthy humans.
It is clinically important to deliver a sustained-release mucoadhesive dosage of local anesthetic and antimicrobial agents for pain control. The current study aimed to develop and evaluate chitosan (CHI) based buccal mucoadhesive delivery for the local release of tibezonium iodide (TBN) and lignocaine hydrochloride (LGN).. Direct compression technique was employed, aided by other mucoadhesive polymers like hydroxypropylmethylcellulose (HPMC) and sodium alginate (SA) and evaluated for physicochemical and. Therefore, the sustained release mucoadhesive dosage form of TBN and LGN can be an effective and alternative option to conventional delivery. Topics: Adhesiveness; Administration, Buccal; Benzodiazepines; Humans; Hypromellose Derivatives; Iodides; Lidocaine; Mouth Mucosa; Pain; Tablets | 2021 |